Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2005Diabetes Obesity and MetabolismOpen Access

Attainment of glycaemic goals in type 2 diabetes with once‐, twice‐, or thrice‐daily dosing with biphasic insulin aspart 70/30 (The 1‐2‐3 study)

View Full Paper
Ask AI
Bookmark
Share

Authors

AGA. J. GarberJWJack WahlenTWTyler S. Wahl

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Garber et al. (2005) studied this question.

synapsesocial.com/papers/6aacb313faf3471d50ca0daehttps://doi.org/10.1111/j.1463-1326.2005.00563.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Treat-to-Target Trial2003 · 1,481 citations
  2. 2The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial1995 · 1,038 citations
  3. 3Insulin Aspart in a 30/70 Premixed Formulation: Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture1997 · 125 citations